IndiaInfoline » Markets » TORNTPHARM

Torrent Pharmaceuticals Ltd - Share Price

TORNTPHARM

Open

1,789.45

Prev. Close

1,779.85

Turnover (lac.)

947

Day's High

1,790.00

Day's Low

1,758.85

52 Week's High

1,962.00

52 Week's Low

1,303.55

Book Value

304

Face Value

5

Mkt Cap (Cr.)

29,769

P/E

37.58

EPS

47.33

Divi. Yield

0.79

Financials

Switch to
Consolidated
Standalone

Loading ...

News & Updates

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd470.95141.74112,564.80-38.680.432,192.4177.62
Piramal Enterprises Ltd2,562.9568.1947,692.45-67.470.95890.351,086.74
Dr Reddys Laboratories Ltd2,897.6037.9047,417.64399.400.702,718.20725.76
Divis Laboratories Ltd1,733.5035.4146,207.46379.490.571,342.92237.46
Aurobindo Pharma Ltd812.4033.3645,968.01463.510.483,160.50180.71

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

sentifi.com

Indiainfoline Sentifi Top 10 Most Talked About Stocks

Summary & Reports

Torrent Pharmaceuticals is one of the leading pharmaceutical companies having presence in Indian and global markets. The company is a dominant player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS). The company also has significant presence in Gastro-Intestinal, Diabetology, Anti-Infective and Pain Management segments. The company has a modern and well-equipped state-of-the-art R&D Centre at Bhat near A... More

Registered Office

Torrent House,Off Ashram Road,Ahmedabad, Gujarat,380009

Tell. : +91-79-26599000
Website : http://www.torrentpharma.com
Email : investorservices@torrentpharma.com

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67161500
Website : www.karvyfintech.com
Email : einward.ris@karvy.com

Latest Release by torrent-pharmaceuticals-ltd

Result Express

Torrent Pharmaceuticals Ltd's Q3FY19 consolidated net profit rises 324.14% yoy to Rs246cr : Beats Estimates

Apr 25, 2019 11:17 AM

The company’s consolidated revenue stood at Rs1,988cr, up 34.6% yoy and 4.96% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Dividend

    Annc. Date

    30 Jan 2019

    Effective. Date

    06 Feb 2019

    Divi. Type

    Interim

    Divi.(%)

    260

    Divi. Amt.

    13

    We would like to inform that the Board has at its meeting held today approved, inter-alia, an interi... More

  • Purpose

    Board Meeting

    Exp. Date

    30 Jan 2019

    Annc. Date

    11 Jan 2019

    TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Compa... More

  • Purpose

    Board Meeting

    Exp. Date

    03 Nov 2018

    Annc. Date

    16 Oct 2018

    TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Compa... More